Merit of an Ursodeoxycholic Acid Clinical Trial in COVID-19 Patients
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Merit of an Ursodeoxycholic Acid Clinical Trial in COVID-19 Patients
Authors
Keywords
-
Journal
Vaccines
Volume 8, Issue 2, Pages 320
Publisher
MDPI AG
Online
2020-06-19
DOI
10.3390/vaccines8020320
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ursodeoxycholic acid attenuates the expression of proinflammatory cytokines in periodontal cells
- (2020) Reza Talebian et al. JOURNAL OF PERIODONTOLOGY
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes
- (2020) James T. England et al. BLOOD REVIEWS
- COVID-19 infection: the perspectives on immune responses
- (2020) Yufang Shi et al. CELL DEATH AND DIFFERENTIATION
- The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
- (2020) Wen Zhang et al. CLINICAL IMMUNOLOGY
- Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment
- (2020) Mehmet Soy et al. CLINICAL RHEUMATOLOGY
- Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19
- (2020) Yang Yang et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- From mice to monkeys, animals studied for coronavirus answers
- (2020) Jon Cohen SCIENCE
- Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
- (2020) Brandi N. Williamson et al. NATURE
- Ursodeoxycholic Acid Regulates Hepatic Energy Homeostasis and White Adipose Tissue Macrophages Polarization in Leptin-Deficiency Obese Mice
- (2019) Yu-Sheng Chen et al. Cells
- Ursodeoxycholic acid stimulates alveolar fluid clearance in LPS‐induced pulmonary edema via ALX/cAMP/PI3K pathway
- (2019) Fangfang Niu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Ursodeoxycholic acid: A promising therapeutic target for inflammatory bowel diseases?
- (2019) Stephen Joseph Keely et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Bile acid metabolites control TH17 and Treg cell differentiation
- (2019) Saiyu Hang et al. NATURE
- Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis
- (2019) Xinyang Song et al. NATURE
- Ursodeoxycholic Acid Inhibits Inflammatory Responses and Promotes Functional Recovery After Spinal Cord Injury in Rats
- (2018) Wan-Kyu Ko et al. MOLECULAR NEUROBIOLOGY
- Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations
- (2018) Aran Singanayagam et al. Nature Communications
- Anti-inflammatory effects of ursodeoxycholic acid by lipopolysaccharide-stimulated inflammatory responses in RAW 264.7 macrophages
- (2017) Wan-Kyu Ko et al. PLoS One
- Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome
- (2016) Chuansheng Guo et al. IMMUNITY
- Oral Solubilized Ursodeoxycholic Acid Therapy in Amyotrophic Lateral Sclerosis: A Randomized Cross-Over Trial
- (2012) Ju-Hong Min et al. JOURNAL OF KOREAN MEDICAL SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search